Divergence between arterial perfusion and fatigue resistance in skeletal muscle in the metabolic syndrome

Experimental Physiology

Volumn 96, Issue 3, 2011, Pages 369-383

  Frisbee, Jefferson C ^a   Goodwill, Adam G ^a   Butcher, Joshua T ^a   Olfert, I Mark ^b  

^a Department of Physiology and Pharmacology ^*  (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; METHACHOLINE; PHENTOLAMINE; PHENYLEPHRINE; TEMPOL; THROMBOXANE;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY PERFUSION; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FATIGUE; GASTROCNEMIUS MUSCLE; HYPERTENSION; METABOLIC SYNDROME X; MUSCLE BLOOD FLOW; MUSCLE FUNCTION; NONHUMAN; OXYGEN CONSUMPTION; RAT; SKELETAL MUSCLE; ZUCKER RAT;

EID: 79951509126     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2010.055418     Document Type: Article

References (39)

1. Adachi T, Kikuchi N, Yasuda K, Anahara R, Gu N, Matsunaga T, Yamamura T, Mori C, Tsujimoto G, Tsuda K & Ishihara A (2007). Fibre type distribution and gene expression levels of both succinate dehydrogenase and peroxisome proliferator-activated receptor-γ coactivator-1α of fibres in the soleus muscle of Zucker diabetic fatty rats. Exp Physiol 92, 449-455.
2. Baron AD (2002). Insulin resistance and vascular function. J Diabetes Complications 16, 92-102.
3. Bouvet C, Belin de Chantemèle E, Guihot AL, Vessières E, Bocquet A, Dumont O, Jardel A, Loufrani L, Moreau P & Henrion D (2007). Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension 50, 248-254.
4. Campion DR, Shapira JF, Allen CE, Hausman GJ & Martin RJ (1987). Metabolic characteristics of skeletal muscle from lean and obese Zucker rats. Growth 51, 397-410.
5. Cannon CP (2008). Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications. Am J Cardiol 102, 5L-9L.
6. Farkas GA, Gosselin LE, Zhan WZ, Schlenker EH & Sieck GC (1994). Histochemical and mechanical properties of diaphragm muscle in morbidly obese Zucker rats. J Appl Physiol 77, 2250-2259.
7. Ford ES & Mokdad AH (2008). Epidemiology of obesity in the Western Hemisphere. J Clin Endocrinol Metab 93, S1-S8.
8. Frisbee JC (2003). Impaired skeletal muscle perfusion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 285, R1124-R1134.
9. Frisbee JC (2004). Enhanced arteriolar α-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats. J Appl Physiol 97, 764-772.
10. Frisbee JC (2005). Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 289, R307-R316.
11. Frisbee JC (2006). Impaired hemorrhage tolerance in the obese Zucker rat model of metabolic syndrome. J Appl Physiol 100, 465-473.
12. Frisbee JC, Hollander JM, Brock RW, Yu HG & Boegehold MA (2009). Integration of skeletal muscle resistance arteriolar reactivity for perfusion responses in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 296, R1771-R1782.
13. Frisbee JC, Maier KG & Stepp DW (2002). Oxidant stress-induced increase in myogenic activation of skeletal muscle resistance arteries in obese Zucker rats. Am J Physiol Heart Circ Physiol 283, H2160-H2168.
14. Goodwill AG, Frisbee SJ, Stapleton PA, James ME & Frisbee JC (2009). Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome. Microcirculation 16, 667-684.
15. Goodwill AG, James ME & Frisbee JC (2008). Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension. Am J Physiol Heart Circ Physiol 295, H1522-H1528.
16. Greene AS, Tonellato PJ, Lui J, Lombard JH & Cowley AW Jr (1989). Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol Heart Circ Physiol 256, H126-H131.
17. Guerre-Millo M (1997). Regulation of ob gene and overexpression in obesity. Biomed Pharmacother 51, 318-323.
18. He D, Bolstad G, Brubakk A & Medbø JI (1995). Muscle fibre type and dimension in genetically obese and lean Zucker rats. Acta Physiol Scand 155, 1-7.
19. Hudlicka O & Brown MD (2009). Adaptation of skeletal muscle microvasculature to increased or decreased blood flow: role of shear stress, nitric oxide and vascular endothelial growth factor. J Vasc Res 46, 504-512.
20. Jones PH (2008). Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering. Am J Cardiol 102, 41L-47L.
21. Katakam PV, Domoki F, Snipes JA, Busija AR, Jarajapu YP & Busija DW (2009). Impaired mitochondria-dependent vasodilation in cerebral arteries of Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 296, R289-R298.
22. Kurdak SS, Grassi B, Wagner PD & Hogan MC (1996). Blood flow distribution in working in situ canine muscle during blood flow reduction. J Appl Physiol 80, 1978-1983.
23. Lu X, Guo X, Karathanasis SK, Zimmerman KM, Onyia JE, Peterson RG & Kassab GS (2010). Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats. Cardiovasc Diabetol 9, 19.
24. Obunai K, Jani S & Dangas GD (2007). Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am 91, 1169-1184.
25. Naik JS, Xiang L & Hester RL (2006). Enhanced role for RhoA-associated kinase in adrenergic-mediated vasoconstriction in gracilis arteries from obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 290, R154-R161.
26. Nicholson CD, Angersbach D & Wilke R (1992). The effect of physical training on rat calf muscle, oxygen tension, blood flow, metabolism and function in an animal model of chronic occlusive peripheral vascular disease. Int J Sports Med 13, 60-64.
27. Pujol A, Lefaucheur L, Ecolan P, Picon L & Penicaud L (1993). Fiber type composition and enzyme activities of muscles in two models of obese rats. Comp Biochem Physiol B 106, 269-272.
28. Roca J, Hogan MC, Story D, Bebout DE, Haab P, Gonzalez R, Ueno O & Wagner PD (1989). Evidence for tissue diffusion limitation of VO2max in normal humans. J Appl Physiol 67, 291-299.
29. Ruiter MS, van Golde JM, Schaper NC, Stehouwer CD & Huijberts MS (2010). Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms. Clin Sci (Lond) 119, 225-238.
30. Schreihofer AM, Hair CD & Stepp DW (2005). Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288, R253-R261.
31. Stepp DW & Frisbee JC (2002). Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 282, H816-H820.
32. Stepp DW, Pollock DM & Frisbee JC (2004). Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol 286, H964-H970.
33. Wagner PD (1992). Gas exchange and peripheral diffusion limitation. Med Sci Sports Exerc 24, 54-58.
34. Williams G, Bing C, Cai XJ, Harrold JA, King PJ & Liu XH (2001). The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav 74, 683-701.
35. Wolfram RM, Budinsky AC & Sinzinger H (2001). Assessment of peripheral arterial vascular disease with radionuclide techniques. Semin Nucl Med 31, 129-42.
36. Xiang L, Dearman J, Abram SR, Carter C & Hester RL (2008). Insulin resistance and impaired functional vasodilation in obese Zucker rats. Am J Physiol Heart Circ Physiol 294, H1658-H1666.
37. Xiang L, Naik JS, Hodnett BL & Hester RL (2006). Altered arachidonic acid metabolism impairs functional vasodilation in metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 290, R134-R138.
38. Zou MH (2007). Peroxynitrite and protein tyrosine nitration of prostacyclin synthase. Prostaglandins Other Lipid Mediat 82, 119-127.
39. Zou MH, Cohen R & Ullrich V (2004). Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11, 89-97.